blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3466946

EP3466946 - THIOPHENE, MANUFACTURING METHOD THEREOF, AND PHARMACEUTICAL APPLICATION OF SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.07.2024
Database last updated on 21.01.2025
FormerThe patent has been granted
Status updated on  28.07.2023
FormerGrant of patent is intended
Status updated on  29.03.2023
FormerExamination is in progress
Status updated on  08.10.2021
FormerRequest for examination was made
Status updated on  08.03.2019
FormerThe international publication has been made
Status updated on  01.12.2017
Most recent event   Tooltip17.01.2025Lapse of the patent in a contracting state
New state(s): LU		published on 19.02.2025 [2025/08]
Applicant(s)For all designated states
Dongbao Purple Star (Hangzhou) Biopharmaceutical Co., Ltd.
Room 1-1008
Heda Parmaceutical Valley Center
No. 291 Fucheng Road
Xiasha Street, Qiantang new District
Hangzhou, Zhejiang 310018 / CN
[N/P]
Former [2023/11]For all designated states
Dongbao Purple Star (Hangzhou) Biopharmaceutical Co., Ltd.
Room 1-1008
Heda Parmaceutical Valley Center
No. 291 Fucheng Road
Xiasha Street, Qiantang new District
Hangzhou, Zhejiang 310018 / CN
Former [2022/17]For all designated states
Dongbao Purple Star (Hangzhou) Biopharmaceutical Co., Ltd.
Room 1-1008
Heda Parmaceutical Valley Center
No. 291 Fucheng Road
Xiasha Street, Qiantang new District
Hangzhou, Zhejiang 310018 / CN
For all designated states
Medshine Discovery Inc.
Room 218, No. 9 Gaoxin Road
Jiangbei New District
Nanjing, Jiangsu 210032 / CN
Former [2022/09]For all designated states
Medshine Discovery Inc.
Room 218, No. 9 Gaoxin Road
Jiangbei New District
Nanjing, Jiangsu 210032 / CN
For all designated states
Dongbao Purple Star (Hangzhou) Biopharmaceutical Co., Ltd.
Room 1-1008
Heda Parmaceutical Valley Center
No. 291 Fucheng Road
Xiasha Street, Qiantang new District
Hangzhou, Zhejiang 310018 / CN
Former [2021/12]For all designated states
Medshine Discovery Inc.
Room 218, No. 9 Gaoxin Road
Jiangbei New District
Nanjing, Jiangsu 210032 / CN
Former [2019/15]For all designated states
CSTONE PHARMACEUTICALS (SHANGHAI) CO., LTD.
Room 211-20, Building 1
38 Debao Road
Pilot Free Trade Zone
Shanghai 200000 / CN
For all designated states
CSTONE PHARMACEUTICAL (SUZHOU) CO., LTD.
218 Xinghu St, Building A1 E168
Suzhou Industrial Park
Jiangsu 215123 / CN
For all designated states
CSTONE PHARMACEUTICALS
P.O. Box 31119, Grand Pavilion
Hibiscus Way
802 West Bay Road
KY1-1205 Grand Cayman / KY
Inventor(s)01 / WANG, Jianfei
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
02 / ZHANG, Yang
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
03 / ZHU, Wenyuan
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
04 / CHEN, Shuhui
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
 [2019/15]
Representative(s)Rösler Rasch van der Heide & Partner
Bodenseestraße 18
81241 München / DE
[2019/15]
Application number, filing date17802137.423.05.2017
[2019/15]
WO2017CN85458
Priority number, dateCN20161034332123.05.2016         Original published format: CN201610343321
[2019/15]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017202291
Date:30.11.2017
Language:ZH
[2017/48]
Type: A1 Application with search report 
No.:EP3466946
Date:10.04.2019
Language:EN
[2019/15]
Type: B1 Patent specification 
No.:EP3466946
Date:30.08.2023
Language:EN
[2023/35]
Search report(s)International search report - published on:CN30.11.2017
(Supplementary) European search report - dispatched on:EP07.10.2019
ClassificationIPC:C07D409/04, C07D405/04, C07D495/04, C07D409/14, A61P19/06, A61K31/381
[2019/44]
CPC:
C07D409/04 (EP,KR,RU,US); C07D405/04 (KR,US); A61K31/357 (KR);
A61K31/381 (RU); A61K31/4196 (KR,RU); A61P19/06 (EP,KR,RU,US);
C07D409/14 (EP,KR,RU,US); C07D495/04 (EP,KR,US) (-)
Former IPC [2019/15]C07D409/04, C07D405/04, C07D495/04, C07D409/14, A61P19/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/15]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:THIOPHEN, HERSTELLUNGSVERFAHREN DAFÜR UND PHARMAZEUTISCHE ANWENDUNG DAVON[2019/15]
English:THIOPHENE, MANUFACTURING METHOD THEREOF, AND PHARMACEUTICAL APPLICATION OF SAME[2019/15]
French:THIOPHÈNE, SON PROCÉDÉ DE FABRICATION, ET APPLICATION PHARMACEUTIQUE CORRESPONDANTE[2019/15]
Entry into regional phase20.12.2018Translation filed 
20.12.2018National basic fee paid 
20.12.2018Search fee paid 
20.12.2018Designation fee(s) paid 
20.12.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
20.12.2018Examination requested  [2019/15]
16.04.2020Amendment by applicant (claims and/or description)
08.10.2021Despatch of a communication from the examining division (Time limit: M04)
01.02.2022Reply to a communication from the examining division
30.03.2023Communication of intention to grant the patent
11.07.2023Receipt of the translation of the claim(s)
25.07.2023Fee for grant paid
25.07.2023Fee for publishing/printing paid
Opposition(s)03.06.2024No opposition filed within time limit [2024/32]
Fees paidRenewal fee
24.05.2019Renewal fee patent year 03
31.03.2020Renewal fee patent year 04
19.05.2021Renewal fee patent year 05
25.05.2022Renewal fee patent year 06
26.05.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT30.08.2023
BG30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
MC30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
LU23.05.2024
[2025/08]
Former [2025/07]AT30.08.2023
BG30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
MC30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/51]AT30.08.2023
BG30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/36]AT30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/23]AT30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/22]AT30.08.2023
CZ30.08.2023
DK30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/20]AT30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
PL30.08.2023
RS30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/10]AT30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
PL30.08.2023
RS30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/09]AT30.08.2023
FI30.08.2023
LT30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/08]LT30.08.2023
NO30.11.2023
GR01.12.2023
Documents cited:Search[X]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20131222), Database accession no. 1500276-99-2, URL: STN, XP002794268 [X] 1-10 * abstract *
 [X]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20140105), Database accession no. 1511846-55-1, URL: STN, XP002794269 [X] 1-10 * abstract *
 [X]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20140106), Database accession no. 1511997-55-9, URL: STN, XP002794270 [X] 1-10 * abstract *
 [X]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20140116), Database accession no. 1521435-55-1, URL: STN, XP002794271 [X] 1-10 * abstract *
 [X]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20160129), Database accession no. 1855720-06-7, URL: STN, XP002794272 [X] 1-10 * abstract *
 [XP]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20160915), Database accession no. 1994072-20-6, URL: STN, XP002794273 [XP] 1-10 * CAS RN: 1994033-22-5 *
 [XP]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20160930), Database accession no. 2002753-00-4, URL: STN, XP002794274 [XP] 1-10 * abstract *
 [XP]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20161003), Database accession no. 2004354-51-0, URL: STN, XP002794275 [XP] 1-10 * abstract *
 [XP]  - REGISTRY, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20161111), Database accession no. 2029569-74-0, XP002794276 [XP] 1-10 * abstract *
International search[A]WO2012050589  (ARDEA BIOSCIENCES INC [US], et al) [A] 1-24 * , the whole document *;
 [A]WO2014077285  (TEIJIN PHARMA LTD [JP]) [A] 1-24 * , the whole document *;
 [A]CN105399694  (ZHEJIANG JINGXIN PHARMACEUTICAL CO LTD, et al) [A] 1-24 * , the whole document *;
 [X]  - REGISTRY, UKRORGSYNTEZLTD, (20160215), Database accession no. 1866384-17-9, URL: STN, XP055445252 [X] 1, 4-8, 11-12, 18-21
 [X]  - REGISTRY, AURORA FINE CHEMICALS, (20140112), Database accession no. 1517276-53-7, URL: STN, XP055445254 [X] 1-2, 4-8, 11-12, 18-21
 [X]  - REGISTRY, AURORA FINE CHEMICALS, (20140110), Database accession no. 1516744-39-0, URL: STN, XP055445257 [X] 1, 4-8, 11-12, 18-21
 [X]  - REGISTRY, AURORA FINE CHEMICALS, (20131230), Database accession no. 1506948-73-7, URL: STN, XP055445259 [X] 1-2, 4-8, 11-12, 18-21
 [X]  - REGISTRY, AURORA FINE CHEMICALS, (20131229), Database accession no. 1506308-08-2, URL: STN, XP055445261 [X] 1-2, 4-8, 11-12, 18-21
 [PX]  - Anonymous, REGISTRY, UKRORGSYNTEZ LTD., (20160916), Database accession no. 2000145-10-6, URL: STN, XP055584157 [PX] 1, 4-8, 11-12, 18-21
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.